Solace Raises $130M in Series C Funding

The patient advocacy platform will grow its national network of care specialists serving Medicare and Medicare Advantage members.

Round size
$130M
Stage
Series C
Headquarters
United States
Announced
Feb 10, 2026

Help between diagnosis and treatment

Solace pairs patients and families with experienced healthcare advocates who help coordinate care and navigate a fragmented system. Its platform supports communication by phone, text and video, serving more than 20,000 patients each month through a network of over 2,000 advocates.

Expanding the advocate network

IVP led the $130 million Series C, valuing Solace above $1 billion. The company will expand its national network, invest in its platform and clinical research, and strengthen payer and provider partnerships.

Sources

  1. Solace: funding announcement
  2. Bloomberg: Solace financing, reproduced by the company
03 / Related rounds

Related funding rounds

01
Series C+ · AI

Anthropic

Claude AI models and tools for coding, analysis and workplace tasks.

Led by GIC, Coatue, D. E. Shaw Ventures, Dragoneer Investment Group, Founders Fund, ICONIQ Capital, MGX
$30B
02
Series C+ · Transportation

Wayve

Wayve uses end-to-end deep learning to develop artificial intelligence capable of complex driving.

Led by SoftBank Vision Fund 2, Eclipse, Balderton Capital
$1.2B
03
Series C+ · Semiconductors

Cerebras Systems

Cerebras Systems builds wafer-scale AI processors and computing systems for training models and running inference, available on premises and through cloud services.

Led by Tiger Global
$1B